5:18 PM ET
10-Q
Financial Results
ProtoKinetix Q1 2026 Results: Net Loss of $77.7K, Loss Narrows
ProtoKinetix, Inc. is a development stage medical research company that reported a net loss of $77,726 for the quarter ended March 31, 2026, compared to a loss of $97,690 in the prior year period. The company maintains a significant accumulated deficit of $48.7 million and faces substantial doubt about its ability to continue as a going concern due to a lack of revenue and minimal cash reserves.
- Key figure
- Net loss $77.7K